MEDizzy
MEDizzy
K
Katiealmost 5 years ago
Psoriasis and beyond: targeting the IL-17 pathway

Psoriasis and beyond: targeting the IL-17 pathway

Psoriasis is a chronic inflammatory skin disorder that affects about 2-3% of the population. It is triggered by the immune system, and new insights into the immune processes have thrown up a number of exciting drug targets. This Nature Reviews Drug Discovery animation explores how the immune system goes awry in psoriasis and illustrates how agents that target the cytokine interleukin 17, or other players in the same pathway, are being developed into novel therapies for psoriasis.

24
Top rated comment
almost 5 years ago

Inflammation pigment cream no five and and a cortisone injection or corticosteroid steroid something for pain and itch

Other commentsSign in to post comments. You don't have an account? Sign up now!

Recent MCQs















Show more MCQs

Recent flashcard sets















Show more flashcards